International Journal of Biological Sciences-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1224854, encodeId=136212248545c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：还是很纠结于预警的事情。说一下投稿注意的事情吧，需要edu邮箱，需要外审专家里面有国外的专家。需要提供原始数据。WB没有裁剪的原图。生信现在基本不要了。综述相对好中。需要一个Graphical Abstract彩图。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/24/c4699d591a16710e3be839693351aaf5.jpg, createdBy=41ed2099615, createdName=1821f639cdm, createdTime=Mon Jun 06 23:00:02 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1239104, encodeId=d8fc1239104c0, content=偏重的研究方向：肿瘤表观遗传 经验分享：想知道大家二审都是多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec96151777, createdName=星回岁杪, createdTime=Tue Aug 16 21:31:45 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062183, encodeId=4bab1062183b0, content=这个杂志真的好慢，录用了之后还要等几个月才见刊，如果急等毕业的要慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Oct 20 09:51:39 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005546, encodeId=e614100554641, content=最近有投的嘛，为什么提交后5天了，状态一点没变过，replace也没有消失, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61e5153216, createdName=1469eb3bm03(暂无昵称), createdTime=Fri Aug 06 08:46:32 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063445, encodeId=9cca1063445f0, content=即时IF8分了！这个杂志上升速度挺快啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11e31646399, createdName=Tanglaoya, createdTime=Sun Oct 24 14:28:42 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省)]

2022-06-06 1821f639cdm

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：还是很纠结于预警的事情。说一下投稿注意的事情吧，需要edu邮箱，需要外审专家里面有国外的专家。需要提供原始数据。WB没有裁剪的原图。生信现在基本不要了。综述相对好中。需要一个Graphical Abstract彩图。

49 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224854, encodeId=136212248545c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：还是很纠结于预警的事情。说一下投稿注意的事情吧，需要edu邮箱，需要外审专家里面有国外的专家。需要提供原始数据。WB没有裁剪的原图。生信现在基本不要了。综述相对好中。需要一个Graphical Abstract彩图。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/24/c4699d591a16710e3be839693351aaf5.jpg, createdBy=41ed2099615, createdName=1821f639cdm, createdTime=Mon Jun 06 23:00:02 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1239104, encodeId=d8fc1239104c0, content=偏重的研究方向：肿瘤表观遗传 经验分享：想知道大家二审都是多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec96151777, createdName=星回岁杪, createdTime=Tue Aug 16 21:31:45 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062183, encodeId=4bab1062183b0, content=这个杂志真的好慢，录用了之后还要等几个月才见刊，如果急等毕业的要慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Oct 20 09:51:39 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005546, encodeId=e614100554641, content=最近有投的嘛，为什么提交后5天了，状态一点没变过，replace也没有消失, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61e5153216, createdName=1469eb3bm03(暂无昵称), createdTime=Fri Aug 06 08:46:32 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063445, encodeId=9cca1063445f0, content=即时IF8分了！这个杂志上升速度挺快啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11e31646399, createdName=Tanglaoya, createdTime=Sun Oct 24 14:28:42 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省)]

2022-12-12 1476a8ddm35暂无昵称来自四川省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：炎症
经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01
动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。

61 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224854, encodeId=136212248545c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：还是很纠结于预警的事情。说一下投稿注意的事情吧，需要edu邮箱，需要外审专家里面有国外的专家。需要提供原始数据。WB没有裁剪的原图。生信现在基本不要了。综述相对好中。需要一个Graphical Abstract彩图。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/24/c4699d591a16710e3be839693351aaf5.jpg, createdBy=41ed2099615, createdName=1821f639cdm, createdTime=Mon Jun 06 23:00:02 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1239104, encodeId=d8fc1239104c0, content=偏重的研究方向：肿瘤表观遗传 经验分享：想知道大家二审都是多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec96151777, createdName=星回岁杪, createdTime=Tue Aug 16 21:31:45 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062183, encodeId=4bab1062183b0, content=这个杂志真的好慢，录用了之后还要等几个月才见刊，如果急等毕业的要慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Oct 20 09:51:39 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005546, encodeId=e614100554641, content=最近有投的嘛，为什么提交后5天了，状态一点没变过，replace也没有消失, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61e5153216, createdName=1469eb3bm03(暂无昵称), createdTime=Fri Aug 06 08:46:32 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063445, encodeId=9cca1063445f0, content=即时IF8分了！这个杂志上升速度挺快啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11e31646399, createdName=Tanglaoya, createdTime=Sun Oct 24 14:28:42 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省)]

2022-08-16 星回岁杪

偏重的研究方向：肿瘤表观遗传
经验分享：想知道大家二审都是多久呀

40 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224854, encodeId=136212248545c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：还是很纠结于预警的事情。说一下投稿注意的事情吧，需要edu邮箱，需要外审专家里面有国外的专家。需要提供原始数据。WB没有裁剪的原图。生信现在基本不要了。综述相对好中。需要一个Graphical Abstract彩图。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/24/c4699d591a16710e3be839693351aaf5.jpg, createdBy=41ed2099615, createdName=1821f639cdm, createdTime=Mon Jun 06 23:00:02 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1239104, encodeId=d8fc1239104c0, content=偏重的研究方向：肿瘤表观遗传 经验分享：想知道大家二审都是多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec96151777, createdName=星回岁杪, createdTime=Tue Aug 16 21:31:45 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062183, encodeId=4bab1062183b0, content=这个杂志真的好慢，录用了之后还要等几个月才见刊，如果急等毕业的要慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Oct 20 09:51:39 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005546, encodeId=e614100554641, content=最近有投的嘛，为什么提交后5天了，状态一点没变过，replace也没有消失, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61e5153216, createdName=1469eb3bm03(暂无昵称), createdTime=Fri Aug 06 08:46:32 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063445, encodeId=9cca1063445f0, content=即时IF8分了！这个杂志上升速度挺快啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11e31646399, createdName=Tanglaoya, createdTime=Sun Oct 24 14:28:42 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省)]

2021-10-20 科研小麻瓜

这个杂志真的好慢，录用了之后还要等几个月才见刊，如果急等毕业的要慎投

124 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224854, encodeId=136212248545c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：还是很纠结于预警的事情。说一下投稿注意的事情吧，需要edu邮箱，需要外审专家里面有国外的专家。需要提供原始数据。WB没有裁剪的原图。生信现在基本不要了。综述相对好中。需要一个Graphical Abstract彩图。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/24/c4699d591a16710e3be839693351aaf5.jpg, createdBy=41ed2099615, createdName=1821f639cdm, createdTime=Mon Jun 06 23:00:02 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1239104, encodeId=d8fc1239104c0, content=偏重的研究方向：肿瘤表观遗传 经验分享：想知道大家二审都是多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec96151777, createdName=星回岁杪, createdTime=Tue Aug 16 21:31:45 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062183, encodeId=4bab1062183b0, content=这个杂志真的好慢，录用了之后还要等几个月才见刊，如果急等毕业的要慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Oct 20 09:51:39 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005546, encodeId=e614100554641, content=最近有投的嘛，为什么提交后5天了，状态一点没变过，replace也没有消失, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61e5153216, createdName=1469eb3bm03(暂无昵称), createdTime=Fri Aug 06 08:46:32 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063445, encodeId=9cca1063445f0, content=即时IF8分了！这个杂志上升速度挺快啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11e31646399, createdName=Tanglaoya, createdTime=Sun Oct 24 14:28:42 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省)]

2021-06-03 ms6000000669997524

偏重的研究方向：细胞;分子生物学
经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗

116 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224854, encodeId=136212248545c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：还是很纠结于预警的事情。说一下投稿注意的事情吧，需要edu邮箱，需要外审专家里面有国外的专家。需要提供原始数据。WB没有裁剪的原图。生信现在基本不要了。综述相对好中。需要一个Graphical Abstract彩图。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/24/c4699d591a16710e3be839693351aaf5.jpg, createdBy=41ed2099615, createdName=1821f639cdm, createdTime=Mon Jun 06 23:00:02 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1239104, encodeId=d8fc1239104c0, content=偏重的研究方向：肿瘤表观遗传 经验分享：想知道大家二审都是多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec96151777, createdName=星回岁杪, createdTime=Tue Aug 16 21:31:45 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062183, encodeId=4bab1062183b0, content=这个杂志真的好慢，录用了之后还要等几个月才见刊，如果急等毕业的要慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Oct 20 09:51:39 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005546, encodeId=e614100554641, content=最近有投的嘛，为什么提交后5天了，状态一点没变过，replace也没有消失, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61e5153216, createdName=1469eb3bm03(暂无昵称), createdTime=Fri Aug 06 08:46:32 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063445, encodeId=9cca1063445f0, content=即时IF8分了！这个杂志上升速度挺快啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11e31646399, createdName=Tanglaoya, createdTime=Sun Oct 24 14:28:42 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省)]

2021-08-06 1469eb3bm03(暂无昵称)

最近有投的嘛，为什么提交后5天了，状态一点没变过，replace也没有消失

104 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224854, encodeId=136212248545c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：还是很纠结于预警的事情。说一下投稿注意的事情吧，需要edu邮箱，需要外审专家里面有国外的专家。需要提供原始数据。WB没有裁剪的原图。生信现在基本不要了。综述相对好中。需要一个Graphical Abstract彩图。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/24/c4699d591a16710e3be839693351aaf5.jpg, createdBy=41ed2099615, createdName=1821f639cdm, createdTime=Mon Jun 06 23:00:02 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1239104, encodeId=d8fc1239104c0, content=偏重的研究方向：肿瘤表观遗传 经验分享：想知道大家二审都是多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec96151777, createdName=星回岁杪, createdTime=Tue Aug 16 21:31:45 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062183, encodeId=4bab1062183b0, content=这个杂志真的好慢，录用了之后还要等几个月才见刊，如果急等毕业的要慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Oct 20 09:51:39 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005546, encodeId=e614100554641, content=最近有投的嘛，为什么提交后5天了，状态一点没变过，replace也没有消失, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61e5153216, createdName=1469eb3bm03(暂无昵称), createdTime=Fri Aug 06 08:46:32 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063445, encodeId=9cca1063445f0, content=即时IF8分了！这个杂志上升速度挺快啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11e31646399, createdName=Tanglaoya, createdTime=Sun Oct 24 14:28:42 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省)]

2021-10-24 Tanglaoya

即时IF8分了！这个杂志上升速度挺快啊！

306 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224854, encodeId=136212248545c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：还是很纠结于预警的事情。说一下投稿注意的事情吧，需要edu邮箱，需要外审专家里面有国外的专家。需要提供原始数据。WB没有裁剪的原图。生信现在基本不要了。综述相对好中。需要一个Graphical Abstract彩图。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/24/c4699d591a16710e3be839693351aaf5.jpg, createdBy=41ed2099615, createdName=1821f639cdm, createdTime=Mon Jun 06 23:00:02 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1239104, encodeId=d8fc1239104c0, content=偏重的研究方向：肿瘤表观遗传 经验分享：想知道大家二审都是多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec96151777, createdName=星回岁杪, createdTime=Tue Aug 16 21:31:45 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062183, encodeId=4bab1062183b0, content=这个杂志真的好慢，录用了之后还要等几个月才见刊，如果急等毕业的要慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Oct 20 09:51:39 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005546, encodeId=e614100554641, content=最近有投的嘛，为什么提交后5天了，状态一点没变过，replace也没有消失, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61e5153216, createdName=1469eb3bm03(暂无昵称), createdTime=Fri Aug 06 08:46:32 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063445, encodeId=9cca1063445f0, content=即时IF8分了！这个杂志上升速度挺快啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11e31646399, createdName=Tanglaoya, createdTime=Sun Oct 24 14:28:42 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省)]

2023-04-27 百年岐黄路来自安徽省

04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing

27 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224854, encodeId=136212248545c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：还是很纠结于预警的事情。说一下投稿注意的事情吧，需要edu邮箱，需要外审专家里面有国外的专家。需要提供原始数据。WB没有裁剪的原图。生信现在基本不要了。综述相对好中。需要一个Graphical Abstract彩图。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/24/c4699d591a16710e3be839693351aaf5.jpg, createdBy=41ed2099615, createdName=1821f639cdm, createdTime=Mon Jun 06 23:00:02 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1239104, encodeId=d8fc1239104c0, content=偏重的研究方向：肿瘤表观遗传 经验分享：想知道大家二审都是多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec96151777, createdName=星回岁杪, createdTime=Tue Aug 16 21:31:45 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062183, encodeId=4bab1062183b0, content=这个杂志真的好慢，录用了之后还要等几个月才见刊，如果急等毕业的要慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Oct 20 09:51:39 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005546, encodeId=e614100554641, content=最近有投的嘛，为什么提交后5天了，状态一点没变过，replace也没有消失, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61e5153216, createdName=1469eb3bm03(暂无昵称), createdTime=Fri Aug 06 08:46:32 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063445, encodeId=9cca1063445f0, content=即时IF8分了！这个杂志上升速度挺快啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11e31646399, createdName=Tanglaoya, createdTime=Sun Oct 24 14:28:42 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省)]

2024-04-17 ms5000000572045221 来自安徽省

大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急

1 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224854, encodeId=136212248545c, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：还是很纠结于预警的事情。说一下投稿注意的事情吧，需要edu邮箱，需要外审专家里面有国外的专家。需要提供原始数据。WB没有裁剪的原图。生信现在基本不要了。综述相对好中。需要一个Graphical Abstract彩图。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/24/c4699d591a16710e3be839693351aaf5.jpg, createdBy=41ed2099615, createdName=1821f639cdm, createdTime=Mon Jun 06 23:00:02 CST 2022, time=2022-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105699, encodeId=a05a2105699ff, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：炎症 经验分享：Received: 2022.10.26; Accepted: 2022.12.05; Published: 2023.01.01 动作很快，一个月不到一审结果就回来了，然后花了5天修回，10天左右就接收了，然后5天就出了proof，真是神速。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221212/08d68660ec5249d4951c3cf19104981b/d48862041d924877a2d8ff1dd10a565a.jpg, createdBy=881a5215169, createdName=1476a8ddm35暂无昵称, createdTime=Mon Dec 12 12:53:27 CST 2022, time=2022-12-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1239104, encodeId=d8fc1239104c0, content=偏重的研究方向：肿瘤表观遗传 经验分享：想知道大家二审都是多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec96151777, createdName=星回岁杪, createdTime=Tue Aug 16 21:31:45 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062183, encodeId=4bab1062183b0, content=这个杂志真的好慢，录用了之后还要等几个月才见刊，如果急等毕业的要慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Wed Oct 20 09:51:39 CST 2021, time=2021-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970567, encodeId=26419e0567ce, content=偏重的研究方向：细胞;分子生物学 经验分享：刚投稿显示的under review → under review消失只有received → replace消失，请问距离送审还有多久呢🥲replace消失代表什么呢，以后是还会变成under review吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210603/3a9c7ef3dd6048b8b686127b5ee0de32/143a4c51a73744e8be200915e0697a2d.jpg, createdBy=8ae95417517, createdName=ms6000000669997524, createdTime=Thu Jun 03 12:47:52 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005546, encodeId=e614100554641, content=最近有投的嘛，为什么提交后5天了，状态一点没变过，replace也没有消失, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61e5153216, createdName=1469eb3bm03(暂无昵称), createdTime=Fri Aug 06 08:46:32 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063445, encodeId=9cca1063445f0, content=即时IF8分了！这个杂志上升速度挺快啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=11e31646399, createdName=Tanglaoya, createdTime=Sun Oct 24 14:28:42 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128638, encodeId=63b12128638e6, content=04-20投稿，显示under review，目前一直有replace这个选项还没消失。等待ing, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/80079F7DA1C9AA3940C8265EFA42EC04/100, createdBy=d6b52501715, createdName=百年岐黄路, createdTime=Thu Apr 27 11:40:20 CST 2023, time=2023-04-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2198950, encodeId=3234219895001, content=大家二审的时间是多久啊，一审给了大修more positive,修回过去20天了还是under review，好着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bc565338941, createdName=ms5000000572045221, createdTime=Wed Apr 17 13:51:38 CST 2024, time=2024-04-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2190996, encodeId=abd32190996d3, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Mon Mar 04 17:18:02 CST 2024, time=2024-03-04, status=1, ipAttribution=河南省)]

2024-03-04 ms6000001702952186 来自河南省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：从23年到现在，中了2篇综述。总体上，这个期刊的难度相对容易，杂志内容水平，其实差不多是6-7分的程度，但是这个杂志有9分。国人占比很高，或许也是因为分数和实际情况不太相符+国人比例过高，在一些医院被拉黑了。9分这个档次，算比较容易

22 7

展开7条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务